Search for: "Human Genome Sciences, Inc." Results 81 - 100 of 125
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Apr 2011, 6:02 am by Mark J. Astarita, Esq.
“Chip” Skowron, a former portfolio manager for six health care-related hedge funds affiliated with FrontPoint Partners LLC, sold hedge fund holdings of Human Genome Sciences Inc. [read post]
13 Apr 2011, 8:57 am by Ashby Jones
In parallel criminal and civil complaints, prosecutors and regulators alleged that in late 2007 and early 2008 his tips to an unnamed portfolio manager enabled the manager’s hedge-fund to avoid $30 million of losses by selling shares in Human Genome Sciences Inc. ahead of negative news about the company’s trial of a drug for hepatitis C, the liver disease. [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
30 Jan 2011, 9:53 pm by Patent Docs
Human Genome Sciences Inc. v. [read post]
24 Jan 2011, 4:55 am
Finally Matt addressed industrial applicability, there being a new case to cite in Eli Lilly v Human Genome Sciences Inc, as well as a string of perpetual motion machines. [read post]
20 Dec 2010, 10:32 am by Kara OBrien
In addition to today’s charges, the Department of Justice and SEC last month announced parallel actions against a French doctor and expert consultant who, while a member of the steering committee overseeing one of Human Genome Science Inc. [read post]
The federal government’s focus on insider trading and hedge funds continues, with the recent filing of a criminal complaint and SEC enforcement action against a French medical doctor, who served on a steering committee overseeing a clinical trial of a drug under development by Human Genome Sciences, Inc. [read post]
16 Nov 2010, 6:13 pm by Darrin Mish
WaferGen Biosystems Inc and Generex Biotechnology Corp have received grants from the IRS and the Department of Health and Human Services under the Qualifying Therapeutic Discovery Project program established under Section 48D of the Internal Revenue Code. [read post]
4 Nov 2010, 1:44 pm by Sheppard Mullin
Myriad Genetics holds several patents covering genomic materials relating to the human Breast Cancer Susceptibility Genes 1 and 2. [read post]
18 Aug 2010, 12:19 am by Kelly
and industrial applicability on 7 October: Eli Lilly & Co v Human Genome Sciences Inc (IPKat) Nuvigil (Armodafinil) – US: Cephalon and Mylan Pharmaceuticals agree to drop two patents from Nuvigil patent suit (Patent Docs) OxyContin (Oxycodone) – Patent infringement complaint filed following a Paragraph IV certification: Purdue Pharma L.P. et al. v. [read post]
11 Aug 2010, 1:15 am
and industrial applicability in Eli Lilly & Co v Human Genome Sciences Inc, noted by the IPKat here, is (according to a normally reliable source whom the Kat thanks) to be heard by the Supreme Court on Thursday 7 October. [read post]
16 Jun 2010, 7:43 am
Features of note include "Invalidity for lack of Industrial Application - The Court of Appeal hands down its decision in ELi Lilly & Co. v Human Genome Sciences Inc", by the IPKat's friend and IPSoc founder Charlotte Weekes (now with Pinsent Masons).The new UK coalition government is publishing an emergency budget next Tuesday, 22 June. [read post]
15 Jun 2010, 4:15 am by Maxwell Kennerly
The Sherman Act has produced almost as many court opinions (over 17,200) as there are protein-coding genes in the human genome (under 25,000). [read post]
20 May 2010, 2:27 pm by Gene Quinn
Funding for this research came from Synthetic Genomics Inc., a company co-founded by Drs. [read post]
15 Apr 2010, 4:27 am
(Spicy IP) Argentina: Argentina’s scientific data laws and TRIPs compliance (IP tango) Chile: Secretary General of International Seed Federation visits Chile, pressures nation to sign UPOV 91 (IP tango) EU: AHP Manufacturing BV v Bureau voor de Industriële Eigendom analysis now in print (The SPC Blog) Hungary: Metropolitan Appeal Court: Preliminary injunction refused concerning combination patent (EPLAW) Hungary: Metropolitan Appeal Court of Budapest upholds decision of Metropolitan… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]